MARKET

AGEN

AGEN

Agenus
NASDAQ
8.54
+0.04
+0.47%
After Hours: 8.64 +0.1 +1.17% 19:38 09/25 EDT
OPEN
8.57
PREV CLOSE
8.50
HIGH
8.68
LOW
8.40
VOLUME
672.40K
TURNOVER
--
52 WEEK HIGH
8.85
52 WEEK LOW
2.710
MARKET CAP
385.68M
P/E (TTM)
3.231
1D
5D
1M
3M
1Y
5Y
1D
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 5d ago
Weekly Report: what happened at AGEN last week (0914-0918)?
Weekly Report · 5d ago
Agenus Price Target Announced at $40.00/Share by Chardan Capital
Dow Jones · 09/18 12:03
Agenus Initiated at Buy by Chardan Capital
Dow Jones · 09/18 12:03
Chardan Capital Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $40
Benzinga · 09/18 11:53
Agenus initiated with a Buy at Chardan
TipRanks · 09/18 09:10
10 small-cap healthcare stocks with the strongest momentum grades
Seeking Alpha · 09/17 14:20
Weekly Report: what happened at AGEN last week (0907-0911)?
Weekly Report · 09/14 10:30
More
About AGEN
Agenus Inc. is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious disease. The Company's primary business is immuno-oncology, which is advancing antibody-based programs to activate innate and adaptive immunity, overcome tumor immune evasion and expand the population of patients from immunotherapy. Its lead clinical program is botensilimab, alone and in combination with balstilimab, is a clinical-stage immuno-oncology asset which may be used as standalone agents or be complimentary to botensilimab plus balstilimab. Its internal discovery and translation platforms support target identification, antibody generation, biomarker analysis, and candidate selection. The Company's clinical and preclinical portfolio include agents directed to CTLA-4, PD-1, CD137, CD73/TGF-beta, ILT2, LAG-3, TIM-3, and TIGIT, all of which remain as proprietary assets of Agenus.

Webull offers Agenus Inc stock information, including NASDAQ: AGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGEN stock methods without spending real money on the virtual paper trading platform.